Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04256746
Other study ID # FDS-NAA-0720
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 24, 2012
Est. completion date October 19, 2012

Study information

Verified date February 2020
Source Unilever R&D
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized, balanced incomplete block design dose response study of efficacy, with 4 different dosages of mulberry fruit powdered extract added to cooked rice compared to a reference treatment (cooked rice only).


Description:

Dose response study with 4 dosages of mulberry fruit powdered extract (0.37, 0.75, 1.12 and 1.5 g) added to cooked rice, compared to cooked rice only(reference) on post prandial blood glucose response in healthy Indian adults.

In addition, 1.5 g of mulberry fruit powdered extract was added to instant rice porridge and compared to instant rice porridge only as positive control (replication of previous research.

In total there were 7 test products in the study: 5 active treatments and 2 reference treatments.

The study was a cross-over study (4 interventions per subject, 4 out of the 7 test products). The recovery period between treatments was at least seven days.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date October 19, 2012
Est. primary completion date October 19, 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Willing to give consent to participate in the study in writing;

- Healthy male and female subjects between = 20 and = 50.0 years of age;

- BMI of =18.0 and = 25.0 kg/m2;

- Apparently healthy: no medical conditions which might effect study measurements as judged by the study physician or measured by questionnaire, and/or assessed by hematology, blood chemistry and urinalysis;

- Willing to comply to study protocol during the study;

- Agreeing to be informed about medically relevant personal test-results by study physician;

- Willing to refrain from drinking of alcohol on and one day before the blood withdrawal;

- Fasting blood glucose value of volunteer is = 3.4 and = 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening;

- Haemoglobin level within clinically acceptable range (for male 12 to 17 gm/dL and for females 11 to 15 gm / dL; both inclusive) as judged by the research physician.

Exclusion Criteria:

- Being an employee of Unilever of Lambda;

- Chronic smokers, tobacco chewers and drinkers;

- Participation in any other biomedical study 3 months before screening visit day of this study and/or participating in any other biomedical study during the screening period;

- High intake of alcohol (>120 mL/week);

- Reported use of medically prescribed/slimming diet;

- Reported participation in night shifts (between 23.00 and 6.00 hrs);

- Use of medication which interferes with study measurements including vitamins, tonics;

- Reported intense exercise =10 h/week;

- Reported weight loss/gain = 10% of body weight in the 6 months preceding screening

- Blood donation for 2 months prior to screening;

- Urine analysis that showed any drug abuse;

- Allergy to any food or cosmetics;

- If female, not being pregnant or planning pregnancy during the study period;

- If female, lactating or has been lactating for 6 weeks before pre-study investigation and/or during the study period.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Boiled Rice

Boiled Rice+0.37 gr mulberry fruit powdered extract

Boiled Rice+0.75 gr mulberry fruit powdered extract

Boiled Rice+1.12 gr mulberry fruit powdered extract

Boiled Rice+1.50 gr mulberry fruit powdered extract

Rice Porridge

Rice porridge+1.50 gr mulberry fruit powdered extract


Locations

Country Name City State
India Lambda Therapeutics Research Ttd (LTRL) Ahmedabad Gujarat

Sponsors (2)

Lead Sponsor Collaborator
Unilever R&D Lambda Therapeutic Research Ltd.

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Other Hydrogen gas in exhaled breath Each time a volunteer produced a 10 ppm hydrogen (or more) above the basal breath hydrogen level during the 7-hour test period, the value was regarded as a "positive". Analyzed before study product administration at 20 minutes before and at 65, 125, 185, 245, 305, 365 and 425 minutes after the ingestion of the study products
Other Intestinal discomfort A questionnaire to assess four aspects of intestinal discomfort (bloating, flatulence, nausea and pain) on scale from 0-3 was completed by the subjects Just before and at 430 minutes after study product administration
Primary Post-prandial blood glucose Glucose concentration in venous plasma Positive incremental Area under the glucose versus time Curve between 0 (before) and 2 hours after test product intake
Secondary Post-prandial insulin Post-prandial serum insulin Total area under the insulin versus time curves between 0 (before) and 2 hours after study product intake
See also
  Status Clinical Trial Phase
Recruiting NCT04578067 - Empowering Immigrant Women for Active and Healthy Lifestyle N/A
Completed NCT03254082 - Glycemic Response of Sorghum N/A
Completed NCT02536066 - Daily Physical Activity After Meals -Long Term Effects on Blood Glucose N/A
Completed NCT00444171 - Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients N/A
Completed NCT00302302 - The Effects of L-arabinose on Intestinal Sucrase Activity in Man Phase 1
Completed NCT04378374 - The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake N/A
Completed NCT04451655 - Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery N/A
Recruiting NCT04989712 - MOReS Freestyle Libre Validation Study N/A
Completed NCT05352724 - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise N/A
Completed NCT04260425 - A Pilot Study Evaluating Oat Polyphenols on Post-prandial Glucose Response N/A
Completed NCT04258501 - Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response N/A
Completed NCT02968498 - Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers N/A
Completed NCT02484313 - The Effect of Snacks on Glycaemic Regulation in Children N/A
Withdrawn NCT01246492 - The Effect of Artificial Sweeteners on Blood Glucose Response N/A
Completed NCT01241253 - Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus Phase 2
Completed NCT03914430 - Breakfast Cereals Consumed in Dairy and Non-dairy Medium: the Effects on Blood Glucose, Satiety and Food Intake N/A
Recruiting NCT05255783 - The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients N/A
Completed NCT05573607 - Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life N/A
Recruiting NCT05585801 - Continuous Glucose Monitoring in Intensive Care Unit N/A
Active, not recruiting NCT03978104 - Impact of Okara and Bio-okara Food Product on Gut and Glycaemic Health in Middle-aged and Older Adults in Singapore N/A